Quick Summary:
The global Diabetic Foot Ulcers and Pressure Ulcers market is on the brink of significant expansion, projected to escalate from an estimated US$4.2 Billion in 2022, to a substantial US$6 Billion by 2030. As the world grapples with the ever-growing burden of chronic diseases, among which diabetes is a front-runner, the relevance, and thus market value, of efficient methods to manage and treat complications such as foot and pressure ulcers, augments unceasingly. This points to a prime opportunity for astute investors, and our report provides invaluable insight and projections to guide your engagement in this market.
The U.S. and China remain headliners within this industry, commanding a substantial chunk collectively. But other regions like Japan, Canada, and Germany are also key players, each with their unique growth trajectories and prospects. Our report details these dynamics meticulously, backed by robust research and data analysis. Furthermore, you'll receive decisive insights about major market competitors, their strategies, and market share, facilitating fine-tuned decision-making. Acquiring this report translates into receiving essential, reliable intel indispensable for lucrative strategizing in the Diabetic Foot Ulcers and Pressure Ulcers market.
Global Diabetic Foot Ulcers and Pressure Ulcers Market to Reach $6 Billion by 2030
The global market for Diabetic Foot Ulcers and Pressure Ulcers estimated at US$4.2 Billion in the year 2022, is projected to reach a revised size of US$6 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030. Diabetic Foot Ulcers, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$3.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pressure Ulcers segment is readjusted to a revised 4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 8% CAGR
The Diabetic Foot Ulcers and Pressure Ulcers market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.Select Competitors (Total 12 Featured) -
- 3M Healthcare
- Acelity L.P.
- B. Braun
- BSN Medical GMBH
- Coloplast A/S
- ConvaTec, Inc.
- Medline Industries, Inc.
- Medtronic PLC
- Molnlycke Health Care AB
- Organogenesis, Inc.
- Smith & Nephew PLC
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Diabetic Foot Ulcers and Pressure Ulcers?
What is the growth rate of the Global Market for Diabetic Foot Ulcers and Pressure Ulcers?
What is the forecasted size of the Global Market for Diabetic Foot Ulcers and Pressure Ulcers?
Who are the key companies in the Global Market for Diabetic Foot Ulcers and Pressure Ulcers?
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 4.2 Billion |
| Forecasted Market Value ( USD | $ 6 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- 3M Healthcare
- Acelity L.P.
- B. Braun
- BSN Medical GMBH
- Coloplast A/S
- ConvaTec, Inc.
- Medline Industries, Inc.
- Medtronic PLC
- Molnlycke Health Care AB
- Organogenesis, Inc.
- Smith & Nephew PLC
